ALGS vs TT · rev $3.6M vs P/E 36, rev $21.32B
Aligos Therapeutics Inc (ALGS) versus Trane Technologies plc (TT) — a side-by-side from cached financials, not a winner call.
Aligos Therapeutics Inc (ALGS) is a biotechnology company listed on US.
Trane Technologies plc (TT) is a building products & equipment company listed on NYSE.
Latest reported ALGS revenue for 2024-12-31 was $3.6M. Net income was -$131.2M. Revenue was down 41.7% from 2023-12-31 to 2024-12-31. ALGS currently screens at market cap $44.1M.
Latest reported TT revenue for 2025-12-31 was $21.32B. Net income was $2.92B. Revenue was up 7.5% from 2024-12-31 to 2025-12-31. TT currently screens at market cap $104.45B and trailing P/E 36.2.
ALGS currently screens at market cap $44.1M. TT currently screens at market cap $104.45B and trailing P/E 36.2.
Not investment advice. Open the ALGS and TT stock pages for the full models.
Not investment advice.